-
Courses
Courses
Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
-
University Life
University Life
Each year more than 4,000 choose University of Galway as their University of choice. Find out what life at University of Galway is all about here.
-
About University of Galway
About University of Galway
Since 1845, University of Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
-
Colleges & Schools
Colleges & Schools
University of Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a range of key areas of expertise.
-
Research & Innovation
Research & Innovation
University of Galway’s vibrant research community take on some of the most pressing challenges of our times.
-
Business & Industry
Guiding Breakthrough Research at University of Galway
We explore and facilitate commercial opportunities for the research community at University of Galway, as well as facilitating industry partnership.
-
Alumni & Friends
Alumni & Friends
There are 128,000 University of Galway alumni worldwide. Stay connected to your alumni community! Join our social networks and update your details online.
-
Community Engagement
Community Engagement
At University of Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
Business & Economics
Dr Ronan Mahon
B.Sc., M.Sc., PhD
Contact Details
Lecturer Above The Bar
J.E Cairnes School of Business & Economics
University of Galway
E: Ronan.Mahon@universityofgalway.ie
J.E Cairnes School of Business & Economics
University of Galway
E: Ronan.Mahon@universityofgalway.ie
Biography
Peer Reviewed Journals
| Year | Publication | |
|---|---|---|
| (2024) | 'Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison'
Mahon, R., Tiwari, S., Heemstra, H., Koch, M., Ferraris, M., Betts, K., Wang, Y., Gao, S. (2024) 'Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison'. Journal of Comparative Effectiveness Research, 13 (3) [DOI] [Details] |
|
| (2022) | 'Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine'
Mahon, R., Vo, P., Pannagl, K., Tiwari, S., Heemstra, H., Ferraris, M., Zhao, J., Betts, K.A. and Proot, P. (2022) 'Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine'. Current Medical Research And Opinion, 39 (1) [Details] |
|
| (2021) | 'Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden'
Mahon, R., Lang, A., Vo, P., Huels, J., Cooney, P., Danyliv, A., Vudumula, U., Vadapalle, S., Maniyar, F. and Goadsby, P.J. (2021) 'Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden'. Pharmacoeconomics, 39 [Details] |
|
| (2020) | 'Economic evaluations in migraine: systematic literature review and a novel approach'
Mahon, R., Huels, J., Hacking, V., Cooney, P., Danyliv, A., Vudumula, U., Vadapalle, S., Vo, P., Maniyar, F.H., Palmer, S. and Goadsby, P.J. (2020) 'Economic evaluations in migraine: systematic literature review and a novel approach'. Journal Of Medical Economics, 23 (8) [Details] |
|
| (2017) | 'Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population'
Bjermer, L., van Boven, J.F., Costa-Scharplatz, M., Keininger, D.L., Gutzwiller, F.S., Lisspers, K., Mahon, R., Olsson, P. and Roche, N., (2017) 'Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population'. Respiratory Research, 18 [Details] |
|
| (2017) | 'How to appropriately extrapolate costs and utilities in cost-effectiveness analysis'
Bojke, L., Manca, A., Asaria, M., Mahon, R., Ren, S. and Palmer, S. (2017) 'How to appropriately extrapolate costs and utilities in cost-effectiveness analysis'. Pharmacoeconomics, 35 [Details] |
Other Journals
| Year | Publication | |
|---|---|---|
| (2016) | 'Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema'
Kourlaba, G; Relakis, J; Mahon, R; Kalogeropoulou, M; Pantelopoulou, G; Kousidou, O; Maniadakis, N. (2016) 'Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema' Cost Effectiveness and Resource Allocation, 14 . [Details] |
|
| (2020) | 'Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach'
Lakhotia, B., Mahon, R., Gutzwiller, F.S., Danyliv, A., Nikolaev, I. and Thokala, P., (2020) 'Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach' International Journal of Chronic Obstructive Pulmonary Disease, 15 . [Details] |
Professional Associations
| Association | Function | From / To | |
|---|---|---|---|
| The Professional Society for Health Economics and Outcomes Research (ISPOR) | Member | / |
Committees
| Committee | Function | From / To | |
|---|---|---|---|
| National Screening Advisory Committee | Committee member | / | |
| Health Economics Association of Ireland | Executive committee member | / |
Education
| Year | Institution | Qualification | Subject | |
|---|---|---|---|---|
| 2010 | University of Edinburgh | M.Sc. | Operational Research | |
| 2015 | University of York | Ph.D. | Economics | |
| 2006 | University of Galway | B.Sc. | Financial Mathematics and Economics |
